Prolonged hepatitis after acute infection with genotype H hepatitis B virus.
We present a case report of a Japanese patient who showed prolonged infection after acute hepatitis B with genotype H. The patient was a 60-year-old man who underwent an annual health care check every year for several years and was never pointed out to have any liver damage, and markers for hepatitis B and C were negative. He was found to be positive for hepatitis B surface antigen (HBsAg) at his health care check in December 2005. After one month, he had an elevated aminotransferase level with hepatitis B e antigen and a high level of serum HBV DNA. He was diagnosed as having acute hepatitis B. On HBV genotype, he had genotype H by the direct sequence method, and he was given a 100 mg of lamivudine daily. However, his acute hepatitis tended to go toward prolonged infection. After two months, he was treated with interferon daily for 28 days. He had negative HBsAg in August 2006. Genotype H, the newest type of hepatitis B, could be the type which shows a poor response to lamivudine. The present paper is the first report, describing the clinical course of acute hepatitis B with genotype H from onset to remission.
Chihara
Norio
N
Department of Hepatology, Toranomon Hospital, Tokyo.
Arase
Yasuji
Y
Suzuki
Fumitaka
F
Suzuki
Yoshiyuki
Y
Kobayashi
Masahiro
M
Akuta
Norio
N
Hosaka
Tetsuya
T
Sezaki
Hitomi
H
Yatsuji
Hiromi
H
Kawamura
Yusuke
Y
Kobayashi
Mariko
M
Watahiki
Sachiyo
S
Ikeda
Kenji
K
Kumada
Hiromitsu
H
D000208:Acute Disease; D000998:Antiviral Agents / Q000627:therapeutic use*; D005838:Genotype; D006509:Hepatitis B / Q000188:drug therapy* / Q000235:genetics; D006515:Hepatitis B virus / Q000145:classification / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016879:Salvage Therapy; D017211:Treatment Failure
D000998:Antiviral Agents; D019259:Lamivudine; D007372:Interferons